Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ares Capital Corporation (ARCC) vs Aspen Aerogels Inc (ASPN) Price & Performance

Ares Capital CorporationTrade
Aspen Aerogels IncTrade

Price performance (Past 24H)

Key statistics

Ares Capital Corporation vs Aspen Aerogels Inc — how do they compare? Ares Capital Corporation trades at $19.95 (market cap $14.35B), while Aspen Aerogels Inc trades at $6.13 (market cap $522.00M). The key difference: Ares Capital Corporation is far larger — about 27.5× Aspen Aerogels Inc's market cap, and Ares Capital Corporation pays a 9.61% dividend while Aspen Aerogels Inc pays none. Which is the better fit depends on your goals.

ARCCASPN
Market Cap
$14.35B$522.00M
Sector
FinancialsTechnology
52-Week High
$22.68$8.82
52-Week Low
$17.45$2.57
Dividend Yield
9.61%
Enterprise Value
$495.40M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ares Capital Corporation

ARCC trades at $20.01, up 1.99% today, with a bullish technical signal from moving averages but neutral oscillators. Recent earnings show Q2 2026 EPS of $0.47, slightly below the $0.4731 estimate, continuing a trend of minor misses. Revenue declined to $1.51B in 2025 from $1.7B in 2024, with net income margin at 81.77%. The stock offers a high dividend yield, with consistent payouts highlighted in recent news.

Outlook is mixed: strong analyst buy consensus (75%) and a stable dividend history support income investors, but declining revenue and tight dividend coverage pose risks. Price target consensus is $19.63, below the current price, suggesting limited upside. Macro risks in private credit, per WSJ on August 9, 2026, add caution.

Aspen Aerogels Inc

ASPN's stock trades at $6.25, down 9.29% in the past 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported a net loss of $389.55M in 2025, with negative profit margins, though Q2 2026 revenue beat estimates and Q3 guidance projects sequential improvement. Recent news highlights growing Thermal Barrier sales and a Supplier of the Year award from General Motors.

The outlook remains speculative; analyst consensus is strongly bullish (82.61% buy ratings), but persistent losses and high cash burn pose significant risks. Upside depends on execution of revenue growth and cost management, while downside risks include competitive pressures and failure to achieve profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.

Read more on ARCC

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.

Read more on ASPN